Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Perin, Laura ^a,b   Sedrakyan, Sargis ^a,b   Giuliani, Stefano ^a,b   Sacco, Stefano Da ^a,b   Carraro, Gianni ^a,b   Shiri, Liron ^a,b   Lemley, Kevin V ^a,b   Rosol, Michael ^a,b   Wu, Sam ^a,b   Atala, Anthony ^c   Warburton, David ^a,b   De Filippo, Roger E ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLYCEROL; UREA; CYTOKINE; LUCIFERASE; MEMBRANE PROTEIN; NEPHRIN; PAX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR PAX2;

ACUTE KIDNEY TUBULE NECROSIS; AMNION FLUID; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EX VIVO STUDY; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; KIDNEY DYSFUNCTION; KIDNEY EPITHELIUM; KIDNEY FAILURE; MOUSE; NONHUMAN; RHABDOMYOLYSIS; STEM CELL; UREA NITROGEN BLOOD LEVEL; ANIMAL; APOPTOSIS; BLOOD; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KARYOTYPING; KIDNEY; KIDNEY TUBULE NECROSIS; LUMINESCENCE; METABOLISM; METHODOLOGY; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION; XENOGRAFT;

AMNIOTIC FLUID; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; CELL PROLIFERATION; CREATININE; CYTOKINES; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENE EXPRESSION; GLYCEROL; HUMANS; KARYOTYPING; KIDNEY; KIDNEY TUBULAR NECROSIS, ACUTE; LUCIFERASES; LUMINESCENT MEASUREMENTS; MEMBRANE PROTEINS; MICE; MICE, NUDE; PAX2 TRANSCRIPTION FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOLYSIS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 77949740465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009357     Document Type: Article

References (29)

1. National Kidney and Urologic Diseases Information Clearinghouse. Kidney and Urologic Diseases Statistics for the United States. Available: http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/index.htm#kpClearinghouse.
2. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334(22): 1448-1460.
3. Yokoo T, Fukui A, Ohashi T, Miyazaki Y, Utsunomiya Y, et al. (2006) Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol 17(4): 1026-1034.
4. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, et al. (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115(7): 1743-1755.
5. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, et al. (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14(6): 1035-1041.
6. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, et al. (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15(7): 1794-1804.
7. Togel F, Hu Z, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289(1): F31-42.
8. Morigi M, Introna M, Imberti B, Corna D, Abbate M, et al. (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26(8): 2075-82.
9. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1): 100-106.
10. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, et al. (2008) Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26(11): 2902-11.
11. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, et al. (2007) Renal differentiation of amniotic fluid stem cells. Cell Prolif 40(6): 936-948.
12. Bonventre JV (2003) Molecular response to cytotoxic injury: role of inflammation, MAP kinases, and endoplasmic reticulum stress response. Semin Nephrol 23(5): 439-448.
13. Humphreys BD, Bonventre JV (2008) Mesenchymal Stem Cells in Acute Kidney Injury. Annu Rev Med 59: 311-325.
14. Lin F (2007) Renal repair: role of bone marrow stem cells. Pediatr Nephrol.
15. Duffield JS, Bonventre JV (2005) Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68(5): 1956-1961.
16. Various authors (1989) Immunodeficient Rodents: A Guide to Their Immunobiology, Husbandry, and Use. Committee on Immunologically Compromised Rodents, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council.
17. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2): 311-20.
18. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16(6): 779-90.
19. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, et al. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178(3): 1041-8.
20. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, et al. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184(2): 741-6.
21. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, et al. (1995) Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28(3): 495-500.
22. Maliszewski CR, Schoenborn MA, Cerretti DP, Wignall JM, Picha KS, et al. (1988) Bovine GM-CSF: molecular cloning and biological activity of the recombinant protein. Mol Immunol 25(9): 843-50.
23. Hu-Li J, Shevach EM, Mizuguchi J, Ohara J, Mosmann T, et al. (1987) B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J Exp Med 1987 Jan 1 165(1): 157-72.
24. Liu C, Bai Y, Ganea D, Hart RP (1995) Species-specific activity of rat recombinant interleukin-1 beta. J Interferon Cytokine Res 15(11): 985-92.
25. Schwabe M, Cox GW, Bosco MC, Prohaska R, Kung HF (1996) Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation. Cell Immunol 168(1): 117-21.
26. Kennedy J, Rossi DL, Zurawski SM, Vega F, Jr., Kastelein RA, et al. (1996) Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J Interferon Cytokine Res 16(8): 611-7.
27. De Haan G, Ausema A, Wilkens M, Molineux G, Dontje B (2000) Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br J Haematol 110(3): 638-46.
28. Semedo P, Palasio CG, Oliveira CD, Feitoza CQ, Gonçalves GM, et al. (2009) Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol; 9(6): 677-82.
29. Wang X, Rosol M, Ge S, Peterson D, McNamara G, et al. (2003) Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 5;102(10): 3478-82.